Home/Filings/4/0001181431-04-042886
4//SEC Filing

CHAPLIN DAVID 4

Accession 0001181431-04-042886

CIK 0000908259other

Filed

Sep 1, 8:00 PM ET

Accepted

Sep 2, 9:43 PM ET

Size

5.6 KB

Accession

0001181431-04-042886

Insider Transaction Report

Form 4
Period: 2004-07-28
CHAPLIN DAVID
Chief Scientific Officer
Transactions
  • Award

    Options to purchase Common Stock

    2004-07-28+50,00050,000 total
    Exercise: $5.03From: 2005-07-28Exp: 2014-07-27Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Options will vest in four equal installments, beginning with the first anniversary of the grant and on each of the three anniversaries thereafter.
  • [F2]Options granted by OXiGENE, Inc. with no consideration paid for such grant.

Issuer

OXIGENE INC

CIK 0000908259

Entity typeother

Related Parties

1
  • filerCIK 0001167232

Filing Metadata

Form type
4
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 9:43 PM ET
Size
5.6 KB